about
Network analysis: a new approach to study endocrine disordersInsights into the pathophysiology of catch-up compared with non-catch-up growth in children born small for gestational age: an integrated analysis of metabolic and transcriptomic data.Signal transduction defects in growth hormone insensitivity.Human growth is associated with distinct patterns of gene expression in evolutionarily conserved networks.Patient selection for IGF-I therapy.3-M syndrome: a growth disorder associated with IGF2 silencing.EVI1 expression in childhood acute lymphoblastic leukaemia is not restricted to MLL and BCR/ABL rearrangements and is influenced by age.Pediatric perspective on pharmacogenomics.Pharmacogenomics related to growth disorders.Serum leptin through childhood and adolescence.The metabolomics of necrotising enterocolitis in preterm babies: an exploratory study.A new missense mutation in the growth hormone-releasing hormone receptor gene in familial isolated GH deficiency.The effect of pegvisomant-induced serum IGF-I normalization on serum leptin levels in patients with acromegaly.Circulating insulin-like growth factor-binding protein 3 levels, independent of insulin-like growth factor 1, associate with truncal fat and systolic blood pressure in South Asian and white European preschool children.Ghrelin concentrations in healthy children and adolescents.Variability in anterior pituitary size within members of a family with GH deficiency due to a new splice mutation in the GHRH receptor gene.Serum insulin-like growth factor-I, IGF binding protein-3 and IGFBP-3 protease activity after cranial irradiation.Constitutional delay of growth and puberty is not commonly associated with mutations in the acid labile subunit geneReduced appetite and body mass index with delayed puberty in a mother and son: association with a rare novel sequence variant in the leptin geneA pilot study to evaluate gene expression profiles in peripheral blood mononuclear cells (PBMCs) from children with GH deficiency and Turner syndrome in response to GH treatmentThe Contributions of Plasma IGF-I, IGFBP-3 and Leptin to Growth in Extremely Premature Infants During the First Two YearsThe Relationship between Nocturnal Urinary Leptin and Gonadotrophins as Children Progress towards PubertyPhenotypic variation in constitutional delay of growth and puberty: relationship to specific leptin and leptin receptor gene polymorphismsIGF-I and IGF-binding protein-3 measurements on filter paper blood spots in children and adolescents on GH treatment: use in monitoring and as markers of growth performanceLeptin measurement in urine in children and its relationship to other growth peptides in serum and urineMonitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growthInfradian rhythms in urinary growth hormone excretionBiochemical tests in the diagnosis of childhood growth hormone deficiency
P50
Q26822484-C60348B3-4F1E-4B84-88D8-DCD995A5C253Q30774194-498E5E2A-FA82-46AA-998B-C867E649D305Q33547970-D98CDAAC-A506-49A5-9873-4F4BC75DF462Q34938931-DECE3A93-4504-42DC-9F74-09179DD17B66Q36409761-621BBF63-1D06-491F-9972-04C545CAF897Q37358224-91DE9A8C-F5F6-4C38-8E10-B17EB73345A3Q37555328-D5714CDC-46D0-4313-93A4-433B179F5CE4Q38162869-9589F453-483D-4FF0-B5A4-99446DC488C9Q38168007-DB3214DB-DD6C-411A-A6D6-0E5CE58C413FQ38345269-19CDC23F-961E-4499-9E10-16E434968A0AQ41197580-B8315753-341F-4889-A872-C23CC156AD00Q44282346-3F8B5C62-3CBC-45A0-BF3B-16B91DD3962CQ44514155-C637F1EB-1F63-48B8-AF56-7D2E46C62386Q44837414-3FB81AEE-7223-444A-A126-4CE5B3F875B4Q47385558-29FCCAC9-3123-4939-BDC7-B77CC5D0FDDFQ47424558-181DC75A-1BE1-4017-A797-0B4B54BC439CQ47695055-0E10C4E4-A245-4C2D-9AB7-1F6A246B5665Q57206669-56DC4CD4-AA52-4C07-A959-94867BE7B8DDQ62511600-02A1A32A-EA2A-4490-A7FD-C36E2DFB7AF6Q62750096-D377F9FA-C8F8-4F67-851A-F519AC71E6A2Q62750170-BFA8B07A-ABD0-4B72-A0F9-62A447B523E5Q62750179-D0488A7D-4C75-4141-9206-3B287618A7C2Q62750195-50EB0CEE-8F6B-486C-9DED-AC5ADADFCE8AQ62750242-B33F26D1-4AB3-4748-AB44-BB83E6F46AA8Q62750246-715AE9B4-1302-4266-8921-E44FEA0A4126Q62750301-CF6D197E-DD02-4A01-8918-9AB0A95A5581Q70871273-35205402-A664-4134-A81D-1AD4321F1711Q73047807-1BDDAA45-76D5-48D5-BB18-DA0038E4CA5F
P50
description
researcher
@en
wetenschapper
@nl
name
Andrew J. Whatmore
@en
Whatmore AJ
@nl
type
label
Andrew J. Whatmore
@en
Whatmore AJ
@nl
altLabel
Whatmore AJ
@en
prefLabel
Andrew J. Whatmore
@en
Whatmore AJ
@nl
P106
P31
P496
0000-0003-2871-7460